Status:
COMPLETED
E. Coli 83972 Induced Asymptomatic Bacteriuria (ABU) in Patients With Recurrent Urinary Tract Infections (UTI)
Lead Sponsor:
Region Skane
Collaborating Sponsors:
Coloplast A/S
Riksförbundet för Trafik, Olycksfall och Polioskadade (RTP), Sundbyberg, Sweden
Conditions:
Urinary Tract Infection
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
This study tests the following hypothesis: Does induced asymptomatic bacteriuria (E. coli 83972) protect against symptomatic urinary tract infections in individuals with bladder emptying dysfunctions ...
Eligibility Criteria
Inclusion
- Recurrent UTI
- Bladder emptying dysfunction
- Optimal conservative treatment incl. clean intermittent catheterization
- Capable of "self reporting of UTI episodes"
Exclusion
- Malignant disease
- Immunosuppression
- Recurrent pyelonephritis
- Abnormalities within upper urinary tract, including renal stones and poor kidney function
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00927316
Start Date
March 1 2003
End Date
December 1 2006
Last Update
November 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Lund University
Lund, Sweden, SE-221 85